EBQ:PEAPETT Study: Difference between revisions

Line 26: Line 26:
cardiac arrest of non-cardiac origin. Resuscitation 2007;72:200–6</ref>. Current ACLS and AHA guidelines suggest that thrombolytics should be considered in cardiac arrests that are thought to be secondary to a PE. This study was created to understand better the usage of tPA, efficacy, and safety in cardiopulmonary arrest in confirmed PE.
cardiac arrest of non-cardiac origin. Resuscitation 2007;72:200–6</ref>. Current ACLS and AHA guidelines suggest that thrombolytics should be considered in cardiac arrests that are thought to be secondary to a PE. This study was created to understand better the usage of tPA, efficacy, and safety in cardiopulmonary arrest in confirmed PE.


This study was a single-center study of 23 patients on whom the group was consulted. All patients had developed cardiopulmonary arrest with PEA and underwent CPR due to massive PE. This cohort was then retrospectively identified via the medical record and followed prospectively on clinical and echocardiographic outcomes.
This study was a single-center study of 23 patients on whom the group was consulted.


==Study Design==
==Study Design==

Revision as of 07:47, 16 May 2020

incomplete Journal Club Article

Sharifi M et al.. "Pulseless electrical activity in pulmonary embolism treated with

thrombolysis (from the “PEAPETT” study)". American Journal of Emergency Medicine. 2016. 34:1963-1967.
PubMed Full text

Clinical Question

Does low dose tissue plasminogen activator (tPA) improve survival in patients with pulseless electrical activity and cardiopulmonary arrest due to confirmed pulmonary embolism?


Conclusion

Rapid administration of 50mg of tPA is safe and effective in achieving ROSC in patients with PEA due to massive pulmonary embolism leading to increased survival and reduction of pulmonary artery pressures

Major Points

Approximately 8%-13% of unexplained cardiac arrests are due to a massive pulmonary embolism (PE)[1]. Current ACLS and AHA guidelines suggest that thrombolytics should be considered in cardiac arrests that are thought to be secondary to a PE. This study was created to understand better the usage of tPA, efficacy, and safety in cardiopulmonary arrest in confirmed PE.

This study was a single-center study of 23 patients on whom the group was consulted.

Study Design

Population

Patient Demographics

Inclusion Criteria

Exclusion Criteria

Interventions

Outcomes

Primary Outcome

Secondary Outcomes

Subgroup analysis

Criticisms & Further Discussion

External Links

See Also

Funding

References

  1. Hess EP, Campbell RL, White RD. Epidemiology, trends, and outcome of out-of hospital cardiac arrest of non-cardiac origin. Resuscitation 2007;72:200–6
Authors: